EU – Lyme IgM Western Blot, Western Blot Test System for the Detection of IgM An
EU – Lyme IgM Western Blot, Western Blot Test System for the Detection of IgM Antibodies to Borrelia afzelii “PKO” and Borrelia garinii, 40 Tests
EU Lyme + VlsE IgG Western Blot, Western Blot Test System for the Detection of I
EU Lyme + VlsE IgG Western Blot, Western Blot Test System for the Detection of IgG Antibodies to Borrelia afzelii “PKO”, Borrelia garinii, and Borrelia burgdorferi VlsE, 40 Tests
Liver (IgG) Marblot Strip Test System, Western Blot System for the Detection of
Liver (IgG) Marblot Strip Test System, Western Blot System for the Detection of IgG Antibody to Liver Antigens, 20 Tests
T. Pallidum IgM Marblot Strip Test System, Western Blot System for the detectio
T. Pallidum IgM Marblot Strip Test System, Western Blot System for the detection of IgM antibody to T. pallidum, 20 Tests
T. Pallidum IgG Marblot Strip Test System, Western Blot System for the detectio
T. Pallidum IgG Marblot Strip Test System, Western Blot System for the detection of IgG antibody to T. pallidum, 20 Tests
Bartels® Cytotoxicity Assay for Clostridium difficile Toxin Product B1029-70, St
Bartels® Cytotoxicity Assay for Clostridium difficile Toxin Product B1029-70, Store Toxi-Titer Plate @ 35-37 °C, Store Reagents @ 2-8 °C, 48 Tests
B. Pertussis PT/FHA EIA Test System, EIA for the detection of antibody to Bordet
B. Pertussis PT/FHA EIA Test System, EIA for the detection of antibody to Bordetella pertussis PT and FHA, 96 Tests
ImmunoCard C. difficile GDH is a rapid qualitative enzyme immunoassay screening
ImmunoCard C. difficile GDH is a rapid qualitative enzyme immunoassay screening test to detect Clostridium difficile antigen, glutamate dehydrogenase, in fecal specimens from persons suspected of having C. difficile infection (CDI). This test does not distinguish between toxigenic and non-toxigenic strains of C. difficile. Samples from patients that produce positive results with this test must be further tested with an assay designed to detect toxigenic C. difficile strains and assist with the diagnosis of CDI.
Premier C. difficile GDH is a qualitative enzyme immunoassay screening test to d
Premier C. difficile GDH is a qualitative enzyme immunoassay screening test to detect Clostridium difficile antigen, glutamate dehydrogenase, in fecal specimens from symptomatic persons suspected of having C. difficile infection (CDI). This test does not distinguish between toxigenic and non-toxigenic strains of C. difficile. Samples from symptomatic patients that produce positive results with this test must be further tested with an assay designed to detect toxigenic C. difficile strains and assist with the diagnosis of CDI.
Bartels® Cytotoxicity Assay for Clostridium difficile Toxin Product B1029-70, St
Bartels® Cytotoxicity Assay for Clostridium difficile Toxin Product B1029-70, Store Toxi-Titer Plate @ 35-37 °C, Store Reagents @ 2-8 °C, 48 Tests
VIDAS ® C. difficile GDH is is a qualitative test for use on VIDAS family instru
VIDAS ® C. difficile GDH is is a qualitative test for use on VIDAS family instruments to detect C. difficile antigen
The C. DIFF QUIK CHEK test is a rapid membrane enzyme immunoassay for use as a
The C. DIFF QUIK CHEK test is a rapid membrane enzyme immunoassay for use as a screening test to detect Clostridium difficile antigen, glutamate dehydrogenase, in fecal specimens from persons suspected of having C. difficile disease. The test does not distinguish toxigenic from nontoxigenic strains of C. difficile. With the use of additional tests that detect C. difficile toxins, the test is to be used as an aid in the diagnosis of C. difficile disease. As with other C. difficile tests, results should be considered in conjunction with the patient history.